Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities

Marco Carotenuto1, Michele Roccella2, Francesco Pisani3

  • 1Sleep Lab for Developmental Age, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, University of Campania "Luigi Vanvitelli", Napoli, Italy.

Behavioural Neurology
|December 31, 2019
PubMed

Insights

Children with Fragile X syndrome (FXS) exhibit significant sleep macrostructure alterations and EEG abnormalities, including interictal epileptiform discharges (IEDs). Early detection of these sleep disturbances is crucial for managing FXS comorbidities.

Area of Science:

  • Genetics
  • Neuroscience
  • Sleep Medicine

Background:

  • Fragile X syndrome (FXS) is a genetic disorder caused by FMR1 gene silencing, impacting FMRP production and leading to intellectual disability.
  • Sleep disturbances are recognized symptoms of FXS, yet detailed polysomnographic (PSG) data in pediatric populations remain scarce.
  • Understanding sleep alterations in FXS is vital for addressing associated neurodevelopmental and behavioral challenges.

Purpose of the Study:

  • To evaluate sleep macrostructure using PSG in children with FXS.
  • To identify and analyze EEG abnormalities in pediatric FXS patients.
  • To compare sleep patterns and EEG findings between children with FXS and typically developing controls.

Main Methods:

  • A multicenter case-control study involving children with FXS and age-matched controls with typical development.
  • Overnight polysomnographic (PSG) recordings were conducted for all participants.
  • Analysis focused on comparing sleep parameters and identifying EEG abnormalities, such as interictal epileptiform discharges (IEDs).

Main Results:

  • Children with FXS demonstrated pathological values across all PSG-recorded sleep parameters compared to controls.
  • Interictal epileptiform discharges (IEDs), including diffuse or focal spikes and sharp waves, were exclusively observed in children with FXS.
  • A potential link between IEDs and circadian sleep-wake cycle alterations suggests dysregulation of inhibitory and excitatory pathways in FXS.

Conclusions:

  • Pediatric FXS is characterized by significant sleep macrostructure disruption and the presence of IEDs.
  • Altered sleep patterns in FXS may exacerbate neuropsychological and behavioral issues, increasing the disease burden.
  • Early identification and management of sleep disturbances are essential for comprehensive FXS patient care and preventing comorbidities.